Spyre Therapeutics, Inc. (SYRE) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Spyre Therapeutics, Inc. (SYRE) quarterly balance sheet — complete assets, liabilities & equity history

Quarterly statement

SYRE Balance Sheet

Spyre Therapeutics, Inc. (SYRE) balance sheet — 12-year assets, liabilities & shareholders' equity history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Total Current Assets	1.1B	1.17B	763.95M	777.78M	504.6M	538.83M	569.77M	608.47M	421.08M	435.74M	487.27M	341.53M	205.95M	239.89M	44.38M	62.26M	82.22M	96.65M	72.6M	98.89M
Cash & Short-Term Investments	1.07B	1.15B	741.47M	756.53M	486.2M	526.58M	564.82M	603.09M	414.23M	426M	484.64M	339.28M	203.6M	235.36M	38.48M	55.71M	73.68M	88.55M	66.72M	93.13M
Cash Only	82.73M	162.01M	97.19M	85.72M	64.9M	81.66M	48.49M	89.42M	71.58M	45.14M	227.55M	188.89M	90.59M	235.36M	35.24M	34.86M	38.99M	37.47M	14.64M	15.14M
Short-Term Investments	989.18M	983.34M	644.28M	670.81M	421.3M	444.92M	516.33M	513.66M	342.65M	380.85M	257.09M	150.38M	113.01M	0	3.23M	20.85M	34.69M	51.08M	52.09M	77.99M
Accounts Receivable	0	0	4.6M	0	0	0	0	0	0	0	0	0	163K	1.65M	330K	375K	669K	479K	1.01M	815K
Days Sales Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	130.68	160.23	285.86	303.49	108.54	60.36	20.58
Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Current Assets	0	27.66M	17.89M	21.25M	18.41M	12.25M	4.95M	5.39M	6.85M	9.74M	2.63M	2.25M	2.19M	2.88M	5.57M	6.17M	0	0	0	0
Total Non-Current Assets	0	0	0	0	0	0	10K	10K	10K	331K	329K	331K	1.32M	3.64M	8.08M	8.89M	9.35M	10.06M	10.57M	11.04M
Property, Plant & Equipment	0	0	0	0	0	0	0	0	0	0	0	0	0	2.32M	6.69M	6.65M	7.07M	7.5M	7.95M	8.36M
Fixed Asset Turnover	-	-	-	-	-	-	-	-	-	-	-	-	-	0.15x	0.03x	0.02x	0.02x	0.08x	0.17x	0.42x
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	0	0	0	0	0	0	0	0	0	321K	0	0	0	0	0	0	1.53M	1.8M	0	0
Other Non-Current Assets	0	0	0	0	0	0	10K	10K	10K	10K	329K	331K	1.32M	1.33M	1.39M	2.24M	749K	752K	2.63M	2.68M
Total Assets	1.1B	1.17B	763.95M	777.78M	504.6M	538.83M	569.78M	608.48M	421.09M	436.07M	487.6M	341.86M	207.26M	243.53M	52.45M	71.14M	91.57M	106.71M	83.17M	109.93M
Asset Turnover	-	-	-	0.14x	-	-	-	-	-	-	-	-	-	0.00x	0.00x	0.00x	0.00x	0.01x	0.01x	0.03x
Asset Growth %	117.94%	117.69%	34.08%	27.82%	19.83%	23.57%	16.85%	77.99%	103.16%	79.06%	829.6%	380.52%	126.36%	128.22%	-36.93%	-35.28%	-29.05%	-27.4%	-49.17%	-31.98%
Total Current Liabilities	40.14M	63.3M	85.16M	58.69M	46.27M	83.06M	70.68M	54.06M	57.54M	22.12M	42.82M	31.98M	44.87M	232.23M	12.64M	14.66M	17.68M	15.86M	16.3M	20.14M
Accounts Payable	9.47M	5.72M	5.69M	8.9M	7.46M	3.71M	3.69M	666K	5.17M	3.23M	3.11M	896K	1.68M	2.85M	2.06M	677K	4.18M	1.96M	2.98M	3.32M
Days Payables Outstanding	-	-	-	16.63	11.35	-	-	-	-	-	-	-	-	-	224.92	455.78	562.26	473.1	570.42	474.84
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0	0	0	0	930K	302K	517K	505K	291K	2.07M	2.36M
Other Current Liabilities	0	37.07M	74.4M	30.94M	16.32M	63.43M	44.74M	31.27M	28.71M	16.23M	5.1M	5.93M	12.88M	182.12M	3.14M	4.92M	7.72M	9.47M	3.11M	4.99M
Current Ratio	27.40x	18.53x	8.97x	13.25x	10.90x	6.49x	8.06x	11.26x	7.32x	19.70x	11.38x	10.68x	4.59x	1.03x	3.51x	4.25x	4.65x	6.09x	4.45x	4.91x
Quick Ratio	27.40x	18.53x	8.97x	13.25x	10.90x	6.49x	8.06x	11.26x	7.32x	19.70x	11.38x	10.68x	4.59x	1.03x	3.51x	4.25x	4.65x	6.09x	4.45x	4.91x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	8.05M	8.56M	7.98M	3.86M	3.23M	0	16.49M	36.62M	36.16M	39.56M	292.51M	125.86M	407.8M	218.66M	6.16M	6.18M	6.33M	6.69M	5.21M	5.84M
Long-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.82M	4M	4.16M	4.32M	4.47M	4.62M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	8.05M	8.56M	7.98M	3.86M	3.23M	0	16.49M	36.62M	36.16M	39.56M	292.51M	125.86M	407.8M	216.32M	0	0	0	0	8K	0
Total Liabilities	48.19M	71.86M	93.14M	62.55M	49.5M	83.06M	87.17M	90.68M	93.7M	61.68M	335.33M	157.84M	452.67M	450.9M	18.8M	20.84M	24.01M	22.55M	21.51M	25.98M
Total Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	4.33M	4.43M	4.63M	4.75M	4.79M	4.92M	5.06M
Net Debt	-82.73M	-162.01M	-97.19M	-85.72M	-64.9M	-81.66M	-48.49M	-89.42M	-71.58M	-45.14M	-227.55M	-188.89M	-90.59M	-231.03M	-30.81M	-30.23M	-34.24M	-32.68M	-9.71M	-10.08M
Debt / Equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.13x	0.09x	0.07x	0.06x	0.08x	0.06x
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Equity	1.05B	1.1B	670.81M	715.24M	455.1M	455.77M	482.61M	517.8M	327.39M	374.38M	152.27M	184.02M	-245.4M	-207.37M	33.65M	50.3M	67.56M	84.16M	61.66M	83.94M
Equity Growth %	131.06%	141.6%	39%	38.13%	39.01%	21.74%	216.95%	181.39%	233.41%	280.54%	352.48%	265.8%	-463.26%	-346.41%	-45.42%	-40.07%	-33.82%	-29.29%	-50.18%	-39.97%
Book Value per Share	11.89	13.00	8.54	9.53	7.53	7.51	8.01	11.01	6.43	8.26	4.17	8.48	-57.15	-54.25	8.93	19.24	17.93	25.59	23.36	42.52
Total Shareholders' Equity	1.05B	1.1B	670.81M	715.24M	455.1M	455.77M	482.61M	517.8M	327.39M	374.38M	152.27M	184.02M	-245.4M	-207.37M	33.65M	50.3M	67.56M	84.16M	61.66M	83.94M
Common Stock	16K	16K	15K	15K	13K	13K	13K	13K	12K	12K	10K	10K	7K	6K	6K	6K	6K	6K	5K	5K
Retained Earnings	-1.33B	-1.23B	-1.2B	-1.13B	-1.07B	-1.05B	-1.02B	-972.43M	-916.14M	-847.11M	-808.27M	-764.41M	-701.23M	-661.13M	-444.05M	-425.62M	-406.8M	-388.57M	-366.25M	-341.81M
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-5.38M	-2.4M	-767K	869K	791K	454K	682K	180K	1.46M	-553K	-363K	302K	-132K	11K	-6K	-48K	-184K	-220K	-153K	-20K
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0